Fulcrum Therapeutics
FULC
$5.73
Share price
-4.18%
Change (1 day)
84.84%
Change (1 year)
Categories
Fulcrum Therapeutics (FULC) - Net assets
Net assets on the balance sheet as of March 2024 : $0.21 B
According to Fulcrum Therapeutics's latest financial reports the company has $0.21 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Fulcrum Therapeutics - Net assets on balance sheet (from 2018 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.23 B | 18.22% |
| 2022-12-31 | $0.19 B | -5.95% |
| 2021-12-31 | $0.21 B | 122.25% |
| 2020-12-31 | $95.18 M | 9.21% |
| 2019-12-31 | $87.15 M | 14.68% |
| 2018-12-31 | $76 M | 5648.87% |
| 2017-12-31 | $1.32 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.32 B | 53.87% | 🇺🇸 USA |